Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is the clinical trial designed to assess the cardiac diastolic function of long term
treatment with teneligliptin compared to that without teneligliptin in patients with type 2
diabetes mellitus by two arms; one includes patients showing E/e' by echocardiography less
than 8, the other includes patients showing E/e' by echocardiography more than 8.